Pharmaceutical Consulting in India | Medium Healthcare Consulting

Pharmaceuticals

Home » Client Segments » Pharmaceuticals

Our Perspective

Over the last five decades, the Indian Pharma industry has grown from strength to strength and has built an enviable global presence. The industry, off-late, is going through structural changes with increased interest in biosimilars, and the focus also moving from infectious diseases to non-communicable diseases. Companies have realized that the days of ‘low hanging fruit’ are over, and many are trying to launch novel therapies, in relatively less-crowded therapeutic areas. Innovative physician and patient outreach programs, especially the ones leveraging digital platforms, are becoming increasingly common.

 

What We Do

Medium Healthcare Consulting has worked on a number of market research and insights projects for some of the leading Indian and global pharmaceutical companies.  The end objectives have been as diverse as Go-To-Market Strategy, Growth Strategy, India Entry Strategy and Communication Strategy. Our strong institutional and KOL connect, and in-depth healthcare expertise gives us unique strengths. Our diverse team of senior consultants conduct all the research on their own, helping derive rich, actionable insights for some of the large pharma majors in India.

We have worked across multiple therapeutic areas such as gastroenterology, cardiovascular diseases, nephrology, diabetes, dental services and also novel therapy areas such as burns treatment.

Here are some illustrative examples of work we have done:

  • Go-to-Market Strategy for a niche dermal substitute for an Indian Pharma MNC
  • Launch sales story for an ultra-long acting insulin, for a global Diabetes Major
  • Growth Strategy for a Nephrology drug facing slow growth
  • Growth Strategy for an existing Gastroenterology drug
  • Brand Planning for an existing drug widely used in Dentistry
  • Perception Mapping and Indication extension for an existing Diabetes drug
  • Deriving growth story for an Undifferentiated drug in the Cardiovascular segment
  • Deriving Communication Messaging for Multi-Channel Marketing
  • Channel Effectiveness Strategy for an OTC drug

Customers who trust us

Dr Reddys logo
gsk logo